Accelerated patent examination procedures spur Japanese university innovation

Nature Biotechnology

Volumn 27, Issue 9, 2009, Pages 815-818

  Tessensohn, John A ^a   Yamamoto, Shusaku ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

JAPANESE UNIVERSITIES; PILOT SYSTEM; PLURIPOTENT STEM CELLS;

PATENTS AND INVENTIONS;

MYC PROTEIN; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR SOX2;

BIOTECHNOLOGICAL PROCEDURES; CLINICAL RESEARCH; DRUG APPROVAL; DRUG DESIGN; ECONOMIC DEVELOPMENT; JAPAN; LICENSING; MASS MEDIUM; MEDICAL ETHICS; PATENT; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; REVIEW; SOMATIC CELL; UNIVERSITY HOSPITAL;

BIOTECHNOLOGY; HUMANS; JAPAN; LICENSURE; PATENTS AS TOPIC; PLURIPOTENT STEM CELLS; UNIVERSITIES;

EID: 70249125102     PISSN: 10870156     EISSN: 15461696     Source Type: Journal    
DOI: 10.1038/nbt0909-815     Document Type: Review

References (29)

1. Patent Term Guarantee Act of 1999, Pub. L. no.106-113, §§4401-4402, 113 Stat. 1501, 1501A-557 (1999).
2. Aida, T. et al. Nat. Biotechnol. 25, 533-535 (2007).
3. Weiss, R. Advance may end stem cell debate. Washington Post (21 november 2007).
4. Arimoto, T. Innovation policy for Japan in a new era. in Recovering from Success: Innovation and Technology Management in Japan (eds. Whittaker, D.H. & Cole, R.e.) 238-242 (Oxford University Press, new York, 2006).
5. Cyranoski, D. Nature 455, 269 (2008).
6. Honda, T. Can Japan retain lead in pluripotent stem cell research? Nihon Keizai Shimbun (27 november 2007).
7. Langreth, R. & Herper, M. Stem cells get real. Forbes (17 June 2008).
8. Ando, K. Government recognizes need for patent strategy to support iPS cell RandD. Nihon Keizai Shimbun (11 January 2008).
9. Cookson, C. & Jack, A. Pfizer to build £41m UK stem cell centre. Financial Times (13 november 2008).
10. Cyranoski, D. Nature 453, 962 (2008).
11. US and Japan to collaborate on stem-cell technology. Nature 458, 958 (2009).
12. iPS Academia Japan, Inc. License Policy. http://www. ips-cell.net/e/ license-policy/index.htm l Kyoto Univ. licenses stem cell patents to 2 biotech firms. Nikkei (9 April, 2009)
13. Ando, K. Universities struggle to turn tech into money. Nikkei Weekly (7 April 2008).
14. Yasuda, F. & Kato, H. WIPO-UnU joint research project- Impact of the intellectual property system on economic growth-Country Report Japan. Measuring the Economic Impact of IP Systems 4 (September 2007).
15. Japan Patent Office. Annual Report 2009 77 (2009) (Japanese version).
16. Japan Science & Technology Agency. Intellectual Property-Domestic Patent Licensing Data Book 2008 (in Japanese only).
17. Vrtovec, K.T. & Scott, C.T. Nat. Biotechnol. 26, 393-395 (2008).
18. Japan Patent Office. Annual Report 2009 130 (2009) (Japanese version). Ibid., 221
19. Tessensohn, J. European Intel. Prop. Rev. 30, 261-268 (2008).
20. Japan Patent Office. Annual Report 2009 10 (2009) (Japanese version).
21. Tessensohn, J.A. & Yamamoto, S. World Intel. Prop. Rep. 22, 9-11 (2008).
22. Japan Patent Office. Examination Activities and Appeal Examination Activities-Patent Prosecution Highway (accessed 1 July 2009).
23. Tessensohn, J.A. & Yamamoto, S. World Intel. Prop. Rep. 23, 8-10 (2009).
24. Johnson, C.A. Japan: Who Governs? The Rise of the Developmental State 74 (W.W. norton & Company, new York, 1995).
25. Tessensohn, J.A. & Yamamoto, S. Nat. Biotechnol. 25, 55-57 (2007).
26. Fed. Reg. 36323 (26 June 2006)
27. Hanft, J.e. & Kerns, S.S. Intel. Prop. & Tech. L.J. 19, 1-7 (2007).
28. Cyranoski, D. Nature 451, 229 (2008).
29. Government selects 24 ?super? medical research projects. Yomiuri Shimbun (19 november 2008).